Skip to content
akaturk Academic measurement

Article detail · 2024 · article

Phytochemical profile by LC-MS/MS analysis and evaluation of antioxidant, antidiabetic, anti-Alzheimer, and anticancer activity of Onobrychis argyrea leaf extracts

YÖKSİS OpenAlex Top 1%
Year2024
Citations51OpenAlex
Citations45Semantic Scholar · 1 influential
Percentile%99.0
FWCI12.221.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q3

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueEuropean Journal of Integrative Medicine
  • Catalog match (ISSN)European Journal of Integrative Medicine
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

51citationsOpenAlex · cited_by_count (cache / database)

50 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2024 Synthesis of pyrrole-heterocyclic derivatives as anti-Alzheimer and antidiabetic candidates: An in vitro-in silico studyCitations 51 · OpenAlex
  2. 2024 Synthesis of pyrrole-heterocyclic derivatives as anti-Alzheimer and antidiabetic candidates: An in vitro-in silico studyCitations 49 · OpenAlex
  3. 2024 New tetrahydro-isoquinoline derivatives as cholinesterase and α-glycosidase inhibitors: Synthesis, characterization, molecular docking & dynamics, ADME prediction, in vitro cytotoxicity and enzyme inhibition studiesCitations 46 · OpenAlex
  4. 2024 New tetrahydro-isoquinoline derivatives as cholinesterase and α-glycosidase inhibitors: Synthesis, characterization, molecular docking & dynamics, ADME prediction, in vitro cytotoxicity and enzyme inhibition studiesCitations 46 · OpenAlex
  5. 2025 Alzheimer’s Disease Drug Design by Synthesis, Characterization, Enzyme Inhibition, In Silico, SAR Analysis and MM-GBSA Analysis of Schiff Bases DerivativesCitations 17 · OpenAlex
  6. 2025 Alzheimer’s Disease Drug Design by Synthesis, Characterization, Enzyme Inhibition, In Silico, SAR Analysis and MM-GBSA Analysis of Schiff Bases DerivativesCitations 17 · OpenAlex
  7. 2025 5-methyl-N-(thiophen-2-ylmethylene)-1H-pyrazole-3-carbohydrazide as potent anticancer agent: Synthesis, spectroscopic characterization, anticancer activity and DFT studiesCitations 12 · OpenAlex
  8. 2025 Synthesis, characterization, crystal structure, molecular docking, and biological studies of Cu, Ni and Co metal complexes of pyrazoleCitations 12 · OpenAlex
  9. 2024 Synthesis, characterization, crystal structure, molecular docking, and biological studies of Cu, Ni and Co metal complexes of pyrazoleCitations 12 · OpenAlex
  10. 2025 Photoorganocatalytic synthesis, characterization, crystal structure of two schiff bases and their In Vitro and In Silico evaluations as cholinesterase inhibitorsCitations 11 · OpenAlex

Authors

9
  1. Esma Kübra Kağan Yeniçeri 1
  2. AHMET ALTAY ERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ 2
  3. MUSTAFA ABDULLAH YILMAZ 3
  4. EKREM KÖKSAL 4
  5. Sevgi Altın 5
  6. parham taslimi 6
  7. ALİ KANDEMİR 7
  8. OĞUZ ÇAKIR 8
  9. abbas tarhan 9